Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Trientine (Exclusively Dosage Form Hkp), Atc A16Ax12 For The Period 01.05.26-30.04.28